San Diego, California — According to state and local economic development sources Evofem Biosciences plans to invest $2,557,468.00 to build out 29,738 square feet of new space in San Diego. The company plans to occupy the new space at 12400 High Bluff Dr Unit #600 in San Diego, on or about March 1, 2021. According to the company website Evofem Biosciences, Inc., is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health. Evofem Biosciences aims to advance the lives of women by developing innovative solutions, such as woman-controlled contraception and potential protection from certain sexually transmitted infections. The Company’s lead product candidate, Phexxi, is currently being reviewed by the U.S. Food and Drug Administration for prevention of pregnancy.

To learn more about Evofem Biosciences, visit http://www.evofem.com/

Company Contact:
Saundra Pelletier, Chief Executive Officer
spelletier@evofem.com
https://www.linkedin.com/in/saundra-pelletier-a2a5b844/
858-847-0123

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved